HCWB (HCW Biologics) OCF Margin %: -24.07% (As of Mar. 2026)

What is HCW Biologics OCF Margin %?

HCW Biologics HCWB +1.82% 39 OCF Margin % is -24.07% as of Mar. 2026. GuruFocus rates HCWB with a GF Score™ of 39/100 and a GF Value™ of $7.29 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 960 Biotechnology companies, HCW Biologics ranks worse than 60.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. HCW Biologics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-1.58 Mil. HCW Biologics's Revenue for the three months ended in Mar. 2026 was $6.54 Mil. Therefore, HCW Biologics's OCF Margin % for the quarter that ended in Mar. 2026 was -24.07%.

As of today, HCW Biologics's current OCF Yield % is -142.81%.

The historical rank and industry rank for HCW Biologics's OCF Margin % or its related term are showing as below:

HCWB' s OCF Margin % Range Over the Past 10 Years
Min: -24800 Med: -554.23 Max: -154.51
Current: -173.71

During the past 7 years, the highest OCF Margin % of HCW Biologics was -154.51%. The lowest was -24800.00%. And the median was -554.23%.

HCWB's OCF Margin % is ranked worse than
60.21% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs HCWB: -173.71

HCW Biologics OCF Margin % Related Terms

HCW Biologics OCF Margin % Historical Data

* Premium members only.

The historical data trend for HCW Biologics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCW Biologics OCF Margin % Chart

HCW Biologics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

-154.51

-792.19

-554.23

-24,800.00

HCW Biologics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-70,280.00	-46,885.71	-20,250.00	-12,429.63	-24.07

HCWB vs MTVA, INTI, HOOK: OCF Margin % Comparison

For the Biotechnology subindustry, HCW Biologics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HCW Biologics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HCW Biologics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where HCW Biologics's OCF Margin % falls into.

Save Embed

39GF Score

HCW Biologics Inc HCWB

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

HCW Biologics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

HCW Biologics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-13.392	/	0.054
	=	-24,800.00 %

HCW Biologics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-1.575	/	6.543
	=	-24.07 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -24.07% mean?

HCW Biologics (HCWB) has a OCF Margin % of -24.07% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on HCW Biologics and its competitors. According to the industry distribution chart, HCW Biologics ranks #578 out of 960 companies in the Biotechnology industry, placing it in the top 60.2%.

Is HCW Biologics' OCF Margin % too high?

HCW Biologics' current OCF Margin % is -24.07%. Based on the distribution chart, HCW Biologics ranks #578 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, HCW Biologics has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does HCW Biologics' OCF Margin % compare to MTVA and INTI?

According to the Biotechnology industry distribution chart, HCW Biologics ranks #578 out of 960 companies for OCF Margin %. This places HCW Biologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on HCW Biologics and its competitors. HCW Biologics's current OCF Margin % is -24.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is HCW Biologics stock overvalued right now?

Based on GuruFocus' analysis, HCW Biologics (HCWB) is currently considered Possible Value Trap. The stock's GF Value™ is $7.29, compared to a current price of $1.12 — trading 84.6% below its estimated fair value. The current OCF Margin % is -24.07%. HCW Biologics' overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For HCW Biologics (HCWB), the current OCF Margin % is -24.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HCW Biologics (HCWB) Overvalued in 2026?

Based on GuruFocus' analysis, HCW Biologics stock appears to be undervalued. The current stock price of $1.12 is trading 84.6% below its estimated GF Value™ of $7.29. GuruFocus considers HCW Biologics to be Possible Value Trap.

Key valuation signals for HCWB:

OCF Margin %: -24.07%
GF Value™: $7.29 vs. price of $1.12 (84.6% below fair value)
GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the HCWB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HCW Biologics Business Description

Industry Healthcare Biotechnology

Comparable Companies MTVA INTI HOOK LNAI ICU MBRX ZEOX LEXX GDTC CYCN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 2929 N. Commerce Parkway, Miramar, FL, USA, 33025

Website https://www.hcwbiologics.com

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

39GF Score

Get the complete analysis for HCWB

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.12

Price

$7.29

GF Value

View HCWB Analysis

See OCF Margin % data for all stocks →